| Income Statement |
| Total Revenue | 104.10M |
|
| Revenues (USD) | 104.10M |
| Cost of Revenue | 67.87M |
| Gross Profit | 36.23M |
| Operating Expenses | 39.91M |
| Research and Development Expense | 6.08M |
| Selling, General and Administrative Expense | 33.83M |
| Operating Income | -3.68M |
| Income Tax Expense | 1.03M |
| Net Income | -1.47M |
| Net Income Common Stock | -1.47M |
| Net Income Common Stock (USD) | -1.47M |
| Consolidated Income | -1.47M |
| Earnings per Basic Share | -0.02 |
| Earnings per Basic Share (USD) | -0.02 |
| Earnings per Diluted Share | -0.02 |
| Earning Before Interest & Taxes (EBIT) | -440.00K |
| Earning Before Interest & Taxes (USD) | -440.00K |
| Weighted Average Shares | 84.68M |
| Weighted Average Shares Diluted | 84.68M |
| Balance Sheet |
| Cash and Equivalents | 327.47M |
| Cash and Equivalents (USD) | 327.47M |
| Trade and Non-Trade Receivables | 87.42M |
| Current Assets | 432.24M |
| Property, Plant & Equipment Net | 34.50M |
| Total Assets | 605.02M |
| Debt Current | 5.37M |
| Total Debt | 17.42M |
| Current Liabilities | 54.87M |
| Debt Non-Current | 12.04M |
| Total Liabilities | 74.90M |
| Accumulated Retained Earnings (Deficit) | -3.65M |
| Accumulated Other Comprehensive Income | -2.43M |
| Shareholders Equity | 530.12M |
| Shareholders Equity (USD) | 530.12M |
| Assets Non-Current | 172.78M |
| Total Debt (USD) | 17.42M |
| Goodwill and Intangible Assets | 123.55M |
| Liabilities Non-Current | 20.03M |
| Trade and Non-Trade Payables | 4.33M |
| Tax Assets | 9.41M |
| Tax Liabilities | 7.69M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 6.51M |
| Net Cash Flow from Financing | -17.58M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -14.59M |
| Capital Expenditure | -3.96M |
| Issuance (Purchase) of Equity Shares | -11.46M |
| Net Cash Flow from Investing | -3.96M |
| Net Cash Flow from Operations | 8.39M |
| Effect of Exchange Rate Changes on Cash | -1.44M |
| Share Based Compensation | 8.45M |